| Net Cash Provided by (Used in) Operating Activities |
$-145,000 |
USD |
32% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$215,000 |
USD |
-78.5% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$-278,000 |
USD |
2.8% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
25,730,540 |
shares |
2% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$-208,000 |
USD |
-141.52% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$100,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$2,566,000 |
USD |
19% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$2,566,000 |
USD |
19% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,089,000 |
USD |
17% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$35,137,000 |
USD |
8.8% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
$310,000 |
USD |
53% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |